Lifecore Biomedical Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

4.20$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Lifecore Biomedical Inc. (LFCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 232 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LFCR
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Total Assets	50	42	41	124	120	108	97	93	100	119	141	151	153	200	206	278	291	314	346	343	358	405	519	541	503	295	275	254	239	232
Current Assets	30	20	16	56	60	46	39	36	44	55	89	91	91	89	82	81	86	91	93	86	81	97	133	157	148	124	117	81	86	82
Cash	5.2	9.2	3.2	6.5	8.7	7.8	3.6	6.5	13	21	63	44	43	28	8.1	22	14	14	14	9.9	5.4	2.9	1.1	0.4	1.2	1.6	1.0	8.5	8.3	17
Cash & Short-Term Investments	5.2	9.2	3.2	6.5	8.7	7.8	3.6	6.5	15	21	63	59	66	48	36	22	15	14	14	9.9	5.4	2.9	1.1	0.4	1.2	1.6	1.0	8.5	8.3	17
Receivables	2.2	2.8	3.0	22	19	23	18	17	16	16	18	20	16	20	23	32	42	47	47	46	46	54	70	76	41	48	38	31	44	34
Inventory	2.7	4.7	7.6	14	15	10	13	11	9.9	14	6.8	7.3	5.8	16	20	22	24	25	25	26	25	32	54	66	63	67	36	40	32	29
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	200	218	137	139	135	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	29	21	27	27	41	36	50	50	50	50	50	55	55	77	69	34	14	14	14	14	14
Intangible Assets	15	14	14	40	37	37	38	38	38	14	8.2	8.2	36	16	16	59	58	57	56	21	23	22	45	38	26	16	4.2	4.2	4.2	4.2
Total Liabilities	15	8.7	8.9	67	69	50	38	30	27	32	29	35	26	68	69	126	111	109	126	131	130	152	249	310	300	187	187	243	238	246
Current Liabilities	15	6.0	6.3	47	55	43	33	27	23	32	22	28	19	28	31	67	51	48	56	57	51	88	137	164	102	79	177	39	30	24
Short-Term Debt	–	0.2	0.1	2.9	21	12	10	6.8	0.5	2.0	0.0	5.1	0.3	4.5	4.3	19	9.9	6.1	8.4	11	7.9	32	62	93	31	46	143	4.9	3.8	1.3
Accounts Payable	0.6	1.4	1.7	24	17	12	13	15	18	13	14	19	12	14	17	23	32	32	35	31	25	35	54	52	16	16	13	16	8.2	5.8
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	87	101	165	98	101	121	127	136
Shareholders' Equity	36	34	32	56	50	56	59	62	72	85	110	114	127	131	136	150	179	203	218	211	227	253	270	231	203	108	88	11	1.3	-14
Retained Earnings	-40	-43	-46	-45	-57	-59	-57	-55	-50	-41	-19	1.5	9.2	13	17	30	52	72	85	73	84	109	110	71	39	-59	-79	-167	-205	-223
Shares Outstanding	11	13	10	16	16	18	24	24	25	26	27	27	27	27	27	26	27	27	27	27	28	28	29	29	29	30	29	37	35	37

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings